Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

High relapse rate seen at week 72 for patients treated with R1626 combination therapy.

Pockros P, Nelson D, Godofsky E, Rodriguez-Torres M, Everson GT, Fried MW, Ghalib R, Harrison S, Nyberg L, Shiffman ML, Chan A, Hill G.

Hepatology. 2008 Oct;48(4):1349-50. doi: 10.1002/hep.22593. No abstract available.

PMID:
18821613
2.

R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin.

Pockros PJ, Nelson D, Godofsky E, Rodriguez-Torres M, Everson GT, Fried MW, Ghalib R, Harrison S, Nyberg L, Shiffman ML, Najera I, Chan A, Hill G.

Hepatology. 2008 Aug;48(2):385-97. doi: 10.1002/hep.22357.

PMID:
18570306
3.

[Treatment with pegylated interferon and ribavirin in patients co-infected by human immunodeficiency virus and hepatitis C virus].

Marcos Sánchez F, Albo Castaño MI, Casallo Blanco S.

Rev Clin Esp. 2007 Mar;207(3):150-1; author reply 151-2. Spanish. No abstract available.

PMID:
17397643
4.

Rapid virological response to peginterferon and ribavirin for hepatitis C genotype 1: the role of weight-based ribavirin exposure.

Yu ML, Dai CY, Huang JF, Chuang WL.

Hepatology. 2008 Sep;48(3):1019-20; author reply 1020-1. doi: 10.1002/hep.22434. No abstract available.

PMID:
18756469
5.

[Long-acting interferon: studies on pegylated interferon].

Ma H, Wang H.

Zhonghua Gan Zang Bing Za Zhi. 2002 Feb;10(1):78-9. Review. Chinese. No abstract available.

PMID:
11856520
6.

[Treatment strategies of acute and chronic hepatitis C].

Gładysz A, Inglot M.

Przegl Epidemiol. 2002;56 Suppl 5:10-5. Review. Polish.

PMID:
15553066
7.

Optimal dosage of ribavirin.

Mangia A, Andriulli A.

Hepatology. 2010 Sep;52(3):1174. doi: 10.1002/hep.23742. No abstract available.

PMID:
20812365
8.

Hepatitis C: Enhancing treatment for hepatitis C among drug users.

Grebely J, Dore GJ.

Nat Rev Gastroenterol Hepatol. 2011 Jan;8(1):11-3. doi: 10.1038/nrgastro.2010.186. Epub 2010 Nov 30. No abstract available.

PMID:
21119610
9.

Treatment of hepatitis C in children.

Aziz S.

J Coll Physicians Surg Pak. 2005 Jun;15(6):317-8. No abstract available.

PMID:
15924831
10.

[HIV/HCV double infection: combination is a clear therapy option].

Reich B.

Dtsch Med Wochenschr. 2004 Jul 9;129(28-29):1590. German. No abstract available.

PMID:
15274242
11.

Hepatitis C treatment, HAART and side effects.

[No authors listed]

TreatmentUpdate. 2001 Nov-Dec;13(7):7-8. No abstract available.

PMID:
11794865
12.

Are viral or host factors predictive of response to interferon-ribavirin in transplant patients with hepatitis C?

Roche B, Samuel D.

J Hepatol. 2010 May;52(5):630-2. doi: 10.1016/j.jhep.2010.01.023. Epub 2010 Feb 18. No abstract available.

13.

[Genotype 1 superresponder treat for only 24 weeks].

[No authors listed]

MMW Fortschr Med. 2005 Dec 15;147(51-52):69. German. No abstract available.

PMID:
16402717
14.

Pegylated interferon-alpha2a and ribavirin in HIV-hepatitis C coinfected patients.

[No authors listed]

Expert Rev Anti Infect Ther. 2004 Jun;2(3):341-2. No abstract available.

PMID:
15490503
15.

Scleromyxedema secondary to hepatitis C virus and successfully treated with antiviral therapy.

Smith JA, Kalimullah FA, Erickson CP, Peng LS.

Dermatol Online J. 2015 Sep 17;21(9). pii: 13030/qt1vt8c3vt.

PMID:
26437283
16.

Pegylated interferon and ribavirin in real life: efficacy versus effectiveness.

de Mattos AZ, de Almeida PR, Tovo CV, de Mattos AA.

Hepatology. 2010 Nov;52(5):1867. doi: 10.1002/hep.23824. No abstract available.

PMID:
20726033
17.

[Treatment of acute hepatitis C with PEG-interferon and ribavirin].

Nicolas I, Pons JA.

Gastroenterol Hepatol. 2003 Apr;26(4):275-6. Spanish. No abstract available.

PMID:
12681125
18.

Treatment of hepatitis C in HIV-coinfected patients at the CROI.

Barreiro P.

AIDS Rev. 2004 Jan-Mar;6(1):63. No abstract available.

PMID:
15168743
19.

Hepatitis C (chronic).

Mohsen A, Norris S.

Clin Evid. 2006 Jun;(15):1061-72. Review. No abstract available.

PMID:
16973044
20.

Treatment of chronic hepatitis C in haemodialysis patients requires more ribavirin.

Slavenburg S, Drenth JP.

Nephrol Dial Transplant. 2008 Jul;23(7):2430; author reply 2430-1. doi: 10.1093/ndt/gfn022. Epub 2008 Apr 9. No abstract available.

PMID:
18400821

Supplemental Content

Support Center